Phase Ib dose-escalation/expansion study of BI 836880, a VEGF/Ang2-blocking nanobody®, in combination with BI 754091, an anti-PD-1 antibody, in patients with advanced solid tumours [Abstract]
| Author: | N. Girard, Björn Hackanson, M. Wermke, F. Barlesi, H. T. Landsteiner, G. Jayadeva, J. Alt |
|---|---|
| Frontdoor URL | https://opus.bibliothek.uni-augsburg.de/opus4/123129 |
| ISSN: | 0923-7534OPAC |
| Parent Title (English): | Annals of Oncology |
| Publisher: | Elsevier BV |
| Place of publication: | Amsterdam |
| Type: | Article |
| Language: | English |
| Year of first Publication: | 2019 |
| Publishing Institution: | Universität Augsburg |
| Release Date: | 2025/07/17 |
| Volume: | 30 |
| Issue: | Supplement 5 |
| First Page: | v659 |
| DOI: | https://doi.org/10.1093/annonc/mdz260.115 |
| Institutes: | Medizinische Fakultät |
| Medizinische Fakultät / Universitätsklinikum | |
| Medizinische Fakultät / Lehrstuhl für Innere Medizin mit Schwerpunkt Hämatologie und Onkologie |
